Unknown

Dataset Information

0

ABO-Incompatible Adult Living Donor Liver Transplantation in the Era of Rituximab: A Systematic Review and Meta-Analysis.


ABSTRACT:

Aim

The primary aim of this study is to compare the short- and long-term outcomes between ABO-incompatible (ABOi) adult living donor liver transplantation (ALDLT) with rituximab prophylaxis and ABO-compatible (ABOc) ALDLT.

Background

The strategy of ABOi liver transplantation (LT) was originated initially to increase the donor pool and to enable liver transplantation in emergency conditions. However, ABOi ALDLT remains a controversial approach in comparison to ABOc ALDLT.

Methods

PubMed, Embase, and the Cochrane Library study search were accomplished to recognize studies comparing ABOi and ABOc ALDLT. Meta-analyses were conducted based on the evaluation of heterogeneity using a fixed-effect model and a random-effect model to assess the short- and long-term outcomes following ABOi ALDLT with rituximab prophylaxis.

Results

Nine studies comprising a total of 3,922 patients (ABOi = 671 and ABOc = 3,251) were identified. There was no significant difference between ABOi and ABOc groups for 1-year, 3-year, and 5-year OS and graft survival, respectively. Moreover, 1-year and 3-year OS and DFS were similar between both groups for HCC patients. However, ABOi ALDLT had higher incidences of CMV infection, AMR, overall biliary complications, and biliary stricture than ABOc ALDLT and had other comparable postoperative complications.

Conclusion

Our meta-analysis included studies comparing ABOi and ABOc ALDLT after the introduction of rituximab in a desensitization protocol for ABOi ALDLT. The results of ABOi ALDLT were comparable with those of ABOc ALDLT. However, biliary complications, CMV infection, and AMR remain a concern in the era of rituximab.

SUBMITTER: Yadav DK 

PROVIDER: S-EPMC6594289 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

ABO-Incompatible Adult Living Donor Liver Transplantation in the Era of Rituximab: A Systematic Review and Meta-Analysis.

Yadav Dipesh Kumar DK   Hua Yong Fei YF   Bai Xueli X   Lou Jianying J   Que Risheng R   Gao Shunling S   Zhang Yun Y   Wang Ji J   Xie Qinfen Q   Edoo Muhammad Ibrahim Alhadi MIA   Chutturghoon Vikram Kumar VK   Liang Tingbo T  

Gastroenterology research and practice 20190611


<h4>Aim</h4>The primary aim of this study is to compare the short- and long-term outcomes between ABO-incompatible (ABOi) adult living donor liver transplantation (ALDLT) with rituximab prophylaxis and ABO-compatible (ABOc) ALDLT.<h4>Background</h4>The strategy of ABOi liver transplantation (LT) was originated initially to increase the donor pool and to enable liver transplantation in emergency conditions. However, ABOi ALDLT remains a controversial approach in comparison to ABOc ALDLT.<h4>Metho  ...[more]

Similar Datasets

| S-EPMC5464783 | biostudies-literature
| S-EPMC6166697 | biostudies-literature
| S-EPMC4159453 | biostudies-literature
| S-EPMC5360260 | biostudies-literature
| S-EPMC8070732 | biostudies-literature
| S-EPMC8236826 | biostudies-literature
2024-10-15 | GSE274052 | GEO
| S-EPMC4276514 | biostudies-literature
| S-EPMC9048132 | biostudies-literature
| S-EPMC6197909 | biostudies-literature